The chemical scaffold of theranostic radiopharmaceuticals: radionuclide, bifunctional chelator, and pharmacokinetics modifying linker
Therapeutic radiopharmaceuticals have been researched extensively in the last decade as
a result of the growing research interest in personalized medicine to improve diagnostic …
a result of the growing research interest in personalized medicine to improve diagnostic …
Significance of 5-S-Cysteinyldopa as a Marker for Melanoma
K Wakamatsu, S Fukushima, A Minagawa… - International journal of …, 2020 - mdpi.com
Melanoma is one of the most lethal and malignant cancers and its incidence is increasing
worldwide, and Japan is not an exception. Although there are numerous therapeutic options …
worldwide, and Japan is not an exception. Although there are numerous therapeutic options …
Discovery and design of radiopharmaceuticals by in silico methods
M Salahinejad, DA Winkler… - Current …, 2022 - ingentaconnect.com
There has been impressive growth in the use of radiopharmaceuticals for therapy, selective
toxic payload delivery, and noninvasive diagnostic imaging of disease. The increasing …
toxic payload delivery, and noninvasive diagnostic imaging of disease. The increasing …
Molecular dynamics simulations with NAMD2
G Bitencourt-Ferreira, WF de Azevedo - Docking Screens for Drug …, 2019 - Springer
X-ray diffraction crystallography is the primary technique to determine the three-dimensional
structures of biomolecules. Although a robust method, X-ray crystallography is not able to …
structures of biomolecules. Although a robust method, X-ray crystallography is not able to …
Computational study of radiopharmaceuticals
ES Demir, E Ozgenc, M Ekinci… - Molecular docking …, 2019 - books.google.com
Radiopharmaceuticals contain radionuclides and pharmaceuticals. Research on
radiopharmaceuticals has been increasing in recent years by increasing the importance of …
radiopharmaceuticals has been increasing in recent years by increasing the importance of …
Molecular Docking Study of Pramipexole Derivatives as Radiopharmaceutical Candidates for Brain Imaging
Neurodegenerative diseases are a global priority disease. According to the World Health
Organization (WHO), it is estimated that by 2050, there will be 152 million people with …
Organization (WHO), it is estimated that by 2050, there will be 152 million people with …